Tumor suppressor proteins, PTEN and p53 serve as negative regulators of cell proliferation in breast cancer and mutations in PTEN and p53 are often associated with the activation of AKT cell survival pathway[49]. This evidence concerns the gene AKT1 and breast carcinoma.